hydralazine and gefitinib

hydralazine has been researched along with gefitinib in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Wadman, M1
Branca, MA1
Duster, T1

Reviews

2 review(s) available for hydralazine and gefitinib

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Medicalisation of race.
    Lancet (London, England), 2007, Feb-24, Volume: 369, Issue:9562

    Topics: Age Distribution; Aged; Antineoplastic Agents; Black or African American; Clinical Trials as Topic; Drug Approval; Drug Combinations; Gefitinib; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Lung Neoplasms; Middle Aged; Patents as Topic; Quinazolines; United States; United States Food and Drug Administration

2007

Other Studies

4 other study(ies) available for hydralazine and gefitinib

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Drug targeting: is race enough?
    Nature, 2005, Jun-23, Volume: 435, Issue:7045

    Topics: Asian People; Black or African American; Drug Combinations; Drug Industry; ErbB Receptors; Gefitinib; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Pharmacogenetics; Quinazolines; United States; United States Food and Drug Administration

2005
BiDil raises questions about race as a marker.
    Nature reviews. Drug discovery, 2005, Volume: 4, Issue:8

    Topics: Biomarkers; Black People; Clinical Trials as Topic; Dihydropyrimidine Dehydrogenase Deficiency; Dihydrouracil Dehydrogenase (NADP); Drug Approval; Drug Combinations; Drug Interactions; ErbB Receptors; Erlotinib Hydrochloride; Fluorouracil; Gefitinib; Heart Failure; Humans; Hydralazine; Isosorbide; Middle Aged; Mutation; National Institutes of Health (U.S.); Polymorphism, Genetic; Quinazolines; Risk Factors; Socioeconomic Factors; Treatment Outcome; United States; Uracil; White People

2005